FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to gastroenterology, and concerns a method of Helicobacter pylori infection eradication. For 14 days, amoxicillin is taken in dosage of 1000 mg orally after meals 3 times a day, esomeprazole 3 times a day in dosage of 40 mg orally before meals, rebamipide in dosage of 100 mg 3 times a day.
EFFECT: invention provides more effective eradication of Helicobacter pylori infection.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
METHOD FOR ERADICATION OF INFECTION HELIOBACTER PYLORY IN STOMACH | 2003 |
|
RU2253449C1 |
METHOD FOR PREVENTING DEVELOPING THROMBOCYTOPENIA IN PATIENTS SUFFERING CHRONIC HEPATITIS C COMBINED WITH Helicobacter pylori INFECTION AND RECEIVING COMBINED ANTIVIRAL THERAPY | 2013 |
|
RU2536285C1 |
METHOD FOR ANTI-HELICOBACTER THERAPY OF STOMACH AND DUODENUM | 2013 |
|
RU2537140C1 |
COMPLEX THERAPY METHOD FOR TREATING DUODENAL PEPTIC ULCER DISEASES ASSOCIATED WITH HELICOBACTER PYLORI | 2006 |
|
RU2318514C2 |
WAY OF TREATMENT OF CHRONIC HELICOBACTER PYLORI-ASSOCIATED GASTRITIS OF GASTRIC REMNANT | 2007 |
|
RU2359673C2 |
METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
METHOD OF TREATING HELICOBACTER PYLORI INFECTION IN ADULTS | 2019 |
|
RU2699567C1 |
METHOD FOR PREVENTING EROSIVE AND ULCERATIVE LESIONS OF STOMACH AND DUODENUM DURING CHEMOTHERAPY | 2023 |
|
RU2806313C1 |
METHOD OF TREATING STOMACH AND DUODENUM DISEASES CAUSED BY Helicobacter pylori IN COMBINATION WITH CARRYING OUT THERAPEUTIC PROCEDURES IN ORAL CAVITY | 2008 |
|
RU2400231C2 |
Authors
Dates
2025-02-19—Published
2024-07-02—Filed